TRUMY News and Press, Terumo Corp. ADR From 02/10/22

Terumo Corporation (TRUMF) Q3 2021 Earnings Conference Call February 10,2022, 6:00 AM ET Company Participants Naoki Muto – Chief Accounting & Financial Officer Conference Call Participants Presentation Naoki Muto I'm the CFO, Muto. I will now explain the third quarter results for t...

Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A - For 30 years, Terumo's radial access product portfolio has changed the way clinicians perform coronary care procedures - PR Newswire SOMERSET, N.J. ...

Terumo Corporation (TRUMF) Q2 2022 Earnings Conference Call November 4, 2021 04:00 ET Company Participants Naoki Muto - Chief Accounting & Financial Officer Shinjiro Sato - President & Chief Executive Officer Conference Call Participants Presentation Naoki Muto I am the CAFO, Muto. I ...

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare PR Newswire TOKYO , Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100 th anniversary. The compan...

The medical devices industry has been performing remarkably well over the past year. And we think this trend will likely continue, driven by rising demand for non-emergency medical procedures and tech integration. Thus, quality medical device stocks ResMed Inc. (RMD), Alcon Inc. (ALC), Terumo...

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy PR Newswire 1 in 3 people will be diagnosed with cancer in their lifetime 1 LAKEWOOD, Colo. and FORT COLLINS, Colo. , Aug. 11, ...

Terumo Corporation (TRUMF) Q1 2022 Results Conference Call August 5, 2021 07:00 AM ET Company Participants Naoki Muto - CFO Presentation Naoki Muto I am the CFO, Muto. I will now explain the first quarter results for the fiscal year ending March 2022. First, the highlights from the quarter. S...

Terumo is set to benefit from a resumption of elective medical procedures in developed markets, but also new product introductions in cardiology, neurology, and diabetes. Winning CSL's plasma collection business gives Terumo a new growth driver with double-digit market growth and attr...

Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology Terumo Europe and University Medical Center Utrecht signed a Memorandum of Understanding PR Newswire LEUVEN, Belgium , July 20, 2021 /PRNewswire/ -- Terumo Europe and...

Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System - Represents the next generation technology for peripheral vascular embolization - PR Newswire SOMERSET, N.J. , July 14, 2021 /PRNewswire/ -- Teru...